BARROW JAMES C has a total of 24 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and thermal processes are BAKTHAVATCHALAM RAJAGOPAL, BUR DANIEL and BISSANTZ CATERINA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Thermal processes | |
#4 | Environmental technology | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Barrow James C | 24 |
#2 | Yang Zhi-Qiang | 8 |
#3 | Selnick Harold G | 6 |
#4 | Coburn Craig A | 5 |
#5 | Rittle Kenneth E | 5 |
#6 | Stauffer Shaun R | 5 |
#7 | Shipe William D | 5 |
#8 | Yang Zhiqiang | 4 |
#9 | Mulhearn James | 4 |
#10 | Nantermet Philippe G | 4 |
Publication | Filing date | Title |
---|---|---|
US2011076230A1 | Novel Substituted Indoles | |
US2010249176A1 | Heterocycle amide t-type calcium channel antagonists | |
US2010216816A1 | Pyrazinyl amide-t type calcium channel antagonists | |
WO2009042094A2 | Hiv protease inhibitors | |
WO2006057945A2 | 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
US2007197571A1 | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |